KST Pharma
Board
1 director, no change since 2023Director (not named in the articles)
since 04-02-2016
earlier manager, until 08-08-2023
listed in the 2025 annual accounts, filed on 21-05-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 08-08-2023
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager (not named in the articles), from 04-02-2016 to 08-08-2023
- Director (not named in the articles), since before 08-08-2023
Control
Founders
,
This company
KST Pharma
Equity €21,112
Profit €140 in 2025
Capital
- Contribution
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €211 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 08-08-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 15 May at 18:00
Shareholders
At incorporation
deed of 08-02-2016 ↗
- 98 shares (98%) · €18,228
- 2 shares (2%) · €372
Capital transactions
Capital over time
- 08-08-2023 Converted to unavailable equity · €20,460
- 08-02-2016 Incorporation · €18,600 · 100 shares